Understanding how metals cause lung cancer through chromosome instability
Chromosome Instability Drives Metal-Induced Lung Cancer
This study is looking into how exposure to certain metals, like hexavalent chromium, might lead to lung cancer by causing changes in our cells, and it's for anyone interested in understanding more about the different factors that can contribute to this disease beyond just smoking.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10877855 on NIH RePORTER |
What this research studies
This research investigates the role of metal exposure, particularly hexavalent chromium, in causing lung cancer by inducing chromosome instability. It aims to uncover the mechanisms behind how these metals contribute to cancer development, focusing on various cell models including human lung fibroblasts and epithelial cells. By studying the structural and numerical changes in chromosomes, the research seeks to provide insights into a significant yet underexplored aspect of lung cancer etiology. The findings could help shift the perception of lung cancer beyond just tobacco use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of exposure to carcinogenic metals or those diagnosed with lung cancer who have never smoked.
Not a fit: Patients who have lung cancer solely due to tobacco use may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention strategies for lung cancer, particularly for non-smokers who are affected by metal exposure.
How similar studies have performed: While the specific focus on metal-induced chromosome instability in lung cancer is relatively novel, there is existing research indicating that understanding carcinogenic mechanisms can lead to significant advancements in cancer treatment.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Wise, John Pierce — University of Louisville
- Study coordinator: Wise, John Pierce
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.